Tag Archives: Atricure

Atricure (ATRC) Gets a Hold Rating from BTIG

In a report released today, Sean Lavin from BTIG maintained a Hold rating on Atricure (NASDAQ: ATRC). The company’s shares closed yesterday at $29.30, close to its 52-week high of $30.96. Lavin wrote: “In Q2, AtriCure reported $51.8M in revenue,

Needham Reiterates a Buy Rating on Atricure

Needham analyst Michael Matson reiterated a Buy rating on Atricure (NASDAQ: ATRC) today and set a price target of $36. The company’s shares closed yesterday at $29.30, close to its 52-week high of $30.96. Matson said: “ATRC’s 2Q18 revenue accelerated

Canaccord Genuity Sticks to Its Buy Rating for Atricure

In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Atricure (NASDAQ: ATRC), with a price target of $37. The company’s shares closed yesterday at $29.30, close to its 52-week high of $30.96. According to

Atricure Gets a Hold Rating from BTIG

BTIG analyst Sean Lavin maintained a Hold rating on Atricure (NASDAQ: ATRC) yesterday. The company’s shares closed yesterday at $27.99. According to TipRanks.com, Lavin is a 5-star analyst with an average return of 16.4% and a 63.7% success rate. Lavin

Needham Believes Atricure (NASDAQ: ATRC) Won’t Stop Here

Needham analyst Michael Matson reiterated a Buy rating on Atricure (NASDAQ: ATRC) today and set a price target of $32. The company’s shares closed on Friday at $26.99, close to its 52-week high of $27.22. Matson wrote: “We have increased

A Director at Atricure is Exercising Options

Today, a Director at Atricure, Mark Lanning, exercised options of Atricure for $101K. This recent transaction increases Mark Lanning’s holding in the company by 11.01% to a total of $1.79 million. In addition to Mark Lanning, 2 other ATRC executives